The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanoma. BRAF mutations have been found in a high percentage of melanoma cell lines and metastases; however, only a few studies with a limited number of specimens have focused on primary melanomas. We examined BRAF exon 15 mutational status in 37 primary invasive melanomas of varying thicknesses, which had undergone a standardized pathology review. BRAF mutational status was determined using direct manual sequencing of PCR products, followed by resequencing separately amplified DNA aliquots to confirm each mutation. BRAF exon 15 mutations were found in 17 of 37 (46%) primary melanomas. Tumor-specific tandem mutations, encoding either V599K, V599R, ...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends,...
Frequent somatic mutation of v-raf murine sarcoma viral oncogene homolog B (BRAF), a downstream effe...
The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanom...
The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanom...
The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanom...
A single-point mutation in exon 15 of the BRAF gene has recently been reported in a high percentage ...
Primary cutaneous melanoma is a cancer arising from melanocytes in the skin. In recent decades the i...
Primary cutaneous melanoma is a cancer arising from melanocytes in the skin. In recent decades the i...
Previous studies have shown frequent mutations in the BRAF (V-raf murine sarcoma viral oncogene homo...
BRAF is one of the most common mutated kinases detected in human cancer, particularly in cases of pr...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends,...
Melanoma is one of the aggressive cancer types. Mutations that lock the BRAF protein in an active st...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends,...
Frequent somatic mutation of v-raf murine sarcoma viral oncogene homolog B (BRAF), a downstream effe...
The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanom...
The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanom...
The RAS/RAF/MAPK pathway likely mediates critical cell proliferation and survival signals in melanom...
A single-point mutation in exon 15 of the BRAF gene has recently been reported in a high percentage ...
Primary cutaneous melanoma is a cancer arising from melanocytes in the skin. In recent decades the i...
Primary cutaneous melanoma is a cancer arising from melanocytes in the skin. In recent decades the i...
Previous studies have shown frequent mutations in the BRAF (V-raf murine sarcoma viral oncogene homo...
BRAF is one of the most common mutated kinases detected in human cancer, particularly in cases of pr...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends,...
Melanoma is one of the aggressive cancer types. Mutations that lock the BRAF protein in an active st...
PURPOSEThe prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression remains inc...
The rationale for using small molecule inhibitors of oncogenic proteins as cancer therapies depends,...
Frequent somatic mutation of v-raf murine sarcoma viral oncogene homolog B (BRAF), a downstream effe...